Cargando…
Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway
Myocardial infarction (MI) refers to the death of cardiomyocytes triggered by a lack of energy due to myocardial ischemia and hypoxia, and silent mating type information regulation 2 homolog 3 (SIRT3) plays an essential role in protecting against myocardial oxidative stress and apoptosis, which are...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405218/ https://www.ncbi.nlm.nih.gov/pubmed/36009184 http://dx.doi.org/10.3390/antiox11081465 |
_version_ | 1784773827024125952 |
---|---|
author | Li, Yeli Feng, Linying Xie, Dianyou Lin, Mu Li, Yiqi Chen, Nana Yang, Danli Gao, Jianmei Zhu, Yizhun Gong, Qihai |
author_facet | Li, Yeli Feng, Linying Xie, Dianyou Lin, Mu Li, Yiqi Chen, Nana Yang, Danli Gao, Jianmei Zhu, Yizhun Gong, Qihai |
author_sort | Li, Yeli |
collection | PubMed |
description | Myocardial infarction (MI) refers to the death of cardiomyocytes triggered by a lack of energy due to myocardial ischemia and hypoxia, and silent mating type information regulation 2 homolog 3 (SIRT3) plays an essential role in protecting against myocardial oxidative stress and apoptosis, which are deemed to be the principal causes of MI. Icariside II (ICS II), one of the main active ingredients of Herbal Epimedii, possesses extensive pharmacological activities. However, whether ICS II can protect against MI is still unknown. Therefore, this study was designed to investigate the effect and possible underlying mechanism of ICS II on MI both in vivo and in vitro. The results showed that pretreatment with ICS II not only dramatically mitigated MI-induced myocardial damage in mice but also alleviated H9c2 cardiomyocyte injury elicited by oxygen and glucose deprivation (OGD), which were achieved by suppressing mitochondrial oxidative stress and apoptosis. Furthermore, ICS II elevated the phosphorylation level of adenosine monophosphate-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) expression, thereby activating SIRT3. However, these protective effects of ICS II on MI injury were largely abolished in SIRT3-deficient mice, manifesting that ICS II-mediated cardioprotective effects are, at least partly, due to the presence of SIRT3. Most interestingly, ICS II directly bound with SIRT3, as reflected by molecular docking, which indicated that SIRT3 might be a promising therapeutic target for ICS II-elicited cardioprotection in MI. In conclusion, our findings illustrate that ICS II protects against MI-induced oxidative injury and apoptosis by targeting SIRT3 through regulating the AMPK/PGC-1α pathway. |
format | Online Article Text |
id | pubmed-9405218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94052182022-08-26 Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway Li, Yeli Feng, Linying Xie, Dianyou Lin, Mu Li, Yiqi Chen, Nana Yang, Danli Gao, Jianmei Zhu, Yizhun Gong, Qihai Antioxidants (Basel) Article Myocardial infarction (MI) refers to the death of cardiomyocytes triggered by a lack of energy due to myocardial ischemia and hypoxia, and silent mating type information regulation 2 homolog 3 (SIRT3) plays an essential role in protecting against myocardial oxidative stress and apoptosis, which are deemed to be the principal causes of MI. Icariside II (ICS II), one of the main active ingredients of Herbal Epimedii, possesses extensive pharmacological activities. However, whether ICS II can protect against MI is still unknown. Therefore, this study was designed to investigate the effect and possible underlying mechanism of ICS II on MI both in vivo and in vitro. The results showed that pretreatment with ICS II not only dramatically mitigated MI-induced myocardial damage in mice but also alleviated H9c2 cardiomyocyte injury elicited by oxygen and glucose deprivation (OGD), which were achieved by suppressing mitochondrial oxidative stress and apoptosis. Furthermore, ICS II elevated the phosphorylation level of adenosine monophosphate-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) expression, thereby activating SIRT3. However, these protective effects of ICS II on MI injury were largely abolished in SIRT3-deficient mice, manifesting that ICS II-mediated cardioprotective effects are, at least partly, due to the presence of SIRT3. Most interestingly, ICS II directly bound with SIRT3, as reflected by molecular docking, which indicated that SIRT3 might be a promising therapeutic target for ICS II-elicited cardioprotection in MI. In conclusion, our findings illustrate that ICS II protects against MI-induced oxidative injury and apoptosis by targeting SIRT3 through regulating the AMPK/PGC-1α pathway. MDPI 2022-07-27 /pmc/articles/PMC9405218/ /pubmed/36009184 http://dx.doi.org/10.3390/antiox11081465 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Yeli Feng, Linying Xie, Dianyou Lin, Mu Li, Yiqi Chen, Nana Yang, Danli Gao, Jianmei Zhu, Yizhun Gong, Qihai Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway |
title | Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway |
title_full | Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway |
title_fullStr | Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway |
title_full_unstemmed | Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway |
title_short | Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway |
title_sort | icariside ii, a naturally occurring sirt3 agonist, protects against myocardial infarction through the ampk/pgc-1α/apoptosis signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405218/ https://www.ncbi.nlm.nih.gov/pubmed/36009184 http://dx.doi.org/10.3390/antiox11081465 |
work_keys_str_mv | AT liyeli icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT fenglinying icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT xiedianyou icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT linmu icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT liyiqi icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT chennana icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT yangdanli icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT gaojianmei icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT zhuyizhun icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway AT gongqihai icarisideiianaturallyoccurringsirt3agonistprotectsagainstmyocardialinfarctionthroughtheampkpgc1aapoptosissignalingpathway |